Literature DB >> 19874396

Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis.

M Witgert1, A R Salamone, A M Strutt, A Jawaid, P J Massman, M Bradshaw, D Mosnik, S H Appel, P E Schulz.   

Abstract

BACKGROUND: Cognitive impairment secondary to frontal lobe atrophy exists in 40-60% of Amyotrophic Lateral Sclerosis (ALS) cases. We aimed to determine the prevalence of frontal-lobe mediated behavioral impairment in (ALS) and to ascertain its relationship to cognitive impairment.
METHODS: Two-hundred and twenty five patients diagnosed with sporadic ALS were evaluated for behavioral dysfunction using the Frontal Systems Behavior Scale (FrSBe), a validated measure used to examine frontal-lobe mediated behaviors, specifically apathy, executive dysfunction and disinhibition; a total behavior score is also provided. Additionally, a subset of patients also underwent a comprehensive neuropsychological evaluation.
RESULTS: Changes in the total FrSBe scores were observed in 24.4% of the patients and 39.6% of the patients had impairment in at least one behavioral domain with symptoms of Apathy being the most common (31.1%). Cognitively impaired ALS patients had worse total (P = 0.05) and apathy scores (P < 0.01); however, behavioral dysfunction was also present in 16% of the cognitively intact patients. Half of the behaviorally intact patients exhibited cognitive impairment. Significant correlations were observed for performance on certain neuropsychological tests (Animal fluency, Block Design, Logical Memory I and Verbal Series Attention Test) and severity of behavioral dysfunction on certain FrSBe sub scores.
CONCLUSIONS: Frontal-lobe mediated behavioral dysfunction appears to be common in ALS. Cognitively impaired ALS patients had greater behavioral dysfunction. Recognition of behavioral and cognitive dysfunction may assist health-care providers and care-givers recognize changes in decision-making capacity and treatment compliance of patients with ALS.

Entities:  

Mesh:

Year:  2009        PMID: 19874396     DOI: 10.1111/j.1468-1331.2009.02801.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  23 in total

1.  Personality disturbances in amyotrophic lateral sclerosis: a case study demonstrating changes in personality without cognitive deficits.

Authors:  Eric J Waldron; Joseph Barrash; Andrea Swenson; Daniel Tranel
Journal:  J Int Neuropsychol Soc       Date:  2014-05-23       Impact factor: 2.892

2.  Diffusion tensor tractography analysis of the corpus callosum fibers in amyotrophic lateral sclerosis.

Authors:  Jee-Eun Kim; Jungsu S Oh; Jung-Joon Sung; Kwang-Woo Lee; In Chan Song; Yoon-Ho Hong
Journal:  J Clin Neurol       Date:  2014-07-03       Impact factor: 3.077

Review 3.  Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.

Authors:  Michael J Strong; Sharon Abrahams; Laura H Goldstein; Susan Woolley; Paula Mclaughlin; Julie Snowden; Eneida Mioshi; Angie Roberts-South; Michael Benatar; Tibor HortobáGyi; Jeffrey Rosenfeld; Vincenzo Silani; Paul G Ince; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-01-05       Impact factor: 4.092

Review 4.  Measuring social cognition in frontotemporal lobar degeneration: a clinical approach.

Authors:  Maria Antonietta Magno; Elisa Canu; Federica Agosta; Massimo Filippi
Journal:  J Neurol       Date:  2021-11-19       Impact factor: 4.849

5.  Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.

Authors:  Jennifer Murphy; Pam Factor-Litvak; Raymond Goetz; Catherine Lomen-Hoerth; Peter L Nagy; Jonathan Hupf; Jessica Singleton; Susan Woolley; Howard Andrews; Daragh Heitzman; Richard S Bedlack; Jonathan S Katz; Richard J Barohn; Eric J Sorenson; Björn Oskarsson; J Americo M Fernandes Filho; Edward J Kasarskis; Tahseen Mozaffar; Yvonne D Rollins; Sharon P Nations; Andrea J Swenson; Boguslawa A Koczon-Jaremko; Hiroshi Mitsumoto
Journal:  Neurology       Date:  2016-01-22       Impact factor: 9.910

6.  Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China.

Authors:  QianQian Wei; XuePing Chen; ZhenZhen Zheng; Rui Huang; XiaoYan Guo; Bei Cao; Bi Zhao; Hui-Fang Shang
Journal:  J Neurol       Date:  2014-09-24       Impact factor: 4.849

Review 7.  Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Colin J Mahoney; Rebekah M Ahmed; William Huynh; Sicong Tu; Jonathan D Rohrer; Richard S Bedlack; Orla Hardiman; Matthew C Kiernan
Journal:  CNS Drugs       Date:  2021-05-15       Impact factor: 5.749

8.  Engaging in patient decision-making in multidisciplinary care for amyotrophic lateral sclerosis: the views of health professionals.

Authors:  Anne Hogden; David Greenfield; Peter Nugus; Matthew C Kiernan
Journal:  Patient Prefer Adherence       Date:  2012-09-27       Impact factor: 2.711

9.  Executive dysfunction predicts social cognition impairment in amyotrophic lateral sclerosis.

Authors:  Tamlyn J Watermeyer; Richard G Brown; Katie C L Sidle; David J Oliver; Christopher Allen; Joanna Karlsson; Catherine M Ellis; Christopher E Shaw; Ammar Al-Chalabi; Laura H Goldstein
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

10.  Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum.

Authors:  Patricia Lillo; Eneida Mioshi; James R Burrell; Matthew C Kiernan; John R Hodges; Michael Hornberger
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.